Medical Technology News

Predictive Genetic Testing and Consumer Wellness Genomics Market Size Garner USD 8.7 billion by 2026

Press release   •   Sep 26, 2019 11:28 EDT

The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 8.7 billion by 2026, registering a CAGR of 13.8% over the forecast period 2019 to 2026. An increased understanding of the use of genetic tests to prevent genetic susceptibility before symptoms factory influences the business progression. Increased sales of these products are also driving the market due to the increasing tendency of physicians.

Improving predictive genetic and consumer genomics kits precision is helped with the introduction of new platform in next generation gene sequencing. Market respondents are committed to adopting new product launch protocols which require minimum technical support and optimum customer satisfaction. Pharmaceutical companies are involved in various contract models for genomics suppliers, which are based on phenotypic and genotypic patient data, to disclose novel therapies. GlaxoSmithKline plc, for example, bought 23andMe client information for the development of a fresh medicine in July 2018, supporting health services focused on patients.

Get Free Sample Pages of Report@ https://www.visionresearchreports.com/report/sample/28946

The services offered by predictive genetic testing and the consumer / genomics market should play a crucial part in discovering personalized therapies and medications in the last analysis. Several DTC companies worldwide give genetic testing products and services that are not primarily aimed at danger of diseases, but that provide data that is used by people in order to provide data with distinct levels of scientific validity to guide their decisions about fitness, nutrition and athlecy.

The growing awareness of health care and population preference for a healthy lifestyle led to the growth of the predictive genetic testing and consumer / genomics market. The worldwide predictive genetic testing & consumer genomics industry is predicted to be driven over the forecast era by factors such as the enhanced attention of the government and other private regulator's towards health care, enhanced genetic testing efficiency & quality, incidence of chronic illnesses & genetic illnesses such as Parkinson's & cystic fibrosis. The growing necessity of understanding the history of one's family also pushes the worldwide market.

Key Players & Strategies

Some of the main market participants are Myriad Genetics, Inc 23andMe, Inc.; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific, Inc.; Genesis Genetics; Abbott Laboratories; Agilent Technologies; BGI; Bio-Rad Laboratories Inc.; Counsyl, Inc.; Illumina, Inc.; and ARUP Laboratories. Several main players have introduced different agreements and models of cooperation between themselves and pharmaceutical producers. These partnerships help to benefit both vertical progress and consequent development.

Request to Buy This Premium Report From Here@ https://www.visionresearchreports.com/report/cart/28946

Market Segmentation

Market By Test Type

  • Predictive Testing
    • Genetic Susceptibility Test
    • Predictive Diagnostics
    • Population Screening
  • Consumer Genomics
  • Wellness Genomics
    • Nutria Genetics
    • Skin & Metabolism Genetics
    • Other

Market By Application

    • Breast & Ovarian Cancer
    • Cardiovascular screening
    • Diabetic Screening & Monitoring
    • Colon Cancer
    • Parkinsonism / Alzheimer’s Disease
    • Urologic screening/ Prostate cancer screening
    • Orthopedic & Musculoskeletal
    • Other cancer screening
    • Other

By Setting Type

  • Professional
  • DTC

By Geography

  • North America.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Key Findings

In clinical practice, high adoption rates for these products for the identification of susceptibility to disease led to the biggest proportion in this section in 2018.

The fastest expanding of the consumer genomics segment is the result of growing knowledge of genetic testing and fresh player entry linked to direct consumer (DTC).

The gynecology and endocrinology related research and diagnostics show a major importance for genetic susceptibility exams so that it can capture the greatest share of income. These studies allow for the identification of adenomyosis, endometriosis or postmenopausal osteoporosis prone genes and mutations.

In breast and ovarian cancer predictive genomics are used most highly because these trials have the ability to identify mutations in BRCA in patients.

In the years ahead, the development of MLH1 predictive exams will boost the development of MSH2 genes for colorectal cancer diagnosis.

The segment development will increase with colorectal screening projects, like mass screening and population screening.

Due to the existence of significant players and elevated adoption rates, North America dominated the market in 2018 with the biggest income share.

The development of such goods in the developing economies in Asia Pacific is anticipated to be significant in the next few years.

Request to Buy This Premium Report From Here@ https://www.visionresearchreports.com/report/cart/28946

Table of Content

Section 1. INDUSTRY OVERVIEW
1.1. Market Definition and Scope
1.1.1. Market Definition of Predictive Genetic Testing and Consumer Wellness Genomics
1.1.2. Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Predictive Genetic Testing and Consumer Wellness Genomics Market By Test Type
1.2.2.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate Comparison By Test Type (2015-2026)
1.2.2.2. Global Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share By Test Type in 2018
1.2.2.3. Predictive Testing
1.2.2.3.1. Genetic Susceptibility Test
1.2.2.3.2. Predictive Diagnostics
1.2.2.3.3. Population Screening
1.2.2.4. Wellness Genomics
1.2.2.5. Consumer Genomics
1.2.2.5.1. Nutria Genetics
1.2.2.5.2. Skin & Metabolism Genetics
1.2.2.5.3. Other
1.2.3. Predictive Genetic Testing and Consumer Wellness Genomics Market By Application
1.2.3.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate Comparison By Application (2015- 2026)
1.2.3.2. Predictive Genetic Testing & Consumer Genomics
1.2.3.2.1. Breast & Ovarian Cancer
1.2.3.2.2. Cardiovascular screening
1.2.3.2.3. Diabetic Screening & Monitoring
1.2.3.2.4. Colon Cancer
1.2.3.2.5. Parkinsonism / Alzheimer’s Disease
1.2.3.2.6. Urologic screening/ Prostate cancer screening
1.2.3.2.7. Orthopedic & Musculoskeletal
1.2.3.2.8. Other cancer screening
1.2.3.2.9. Other
1.2.4. Predictive Genetic Testing and Consumer Wellness Genomics Market By Setting Type
1.2.4.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate Comparison By Setting Type (2015-2026)
1.2.4.2. Professional
1.2.4.3. DTC
1.2.5. Predictive Genetic Testing and Consumer Wellness Genomics Market by Geography
1.2.5.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate (2015-2026)

Section 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

Section 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Predictive Genetic Testing and Consumer Wellness Genomics Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Predictive Genetic Testing and Consumer Wellness Genomics Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Predictive Genetic Testing and Consumer Wellness Genomics Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Predictive Genetic Testing and Consumer Wellness Genomics Major Manufacturers in 2018

Section 4. PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY TEST TYPE
4.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Revenue By Test Type
4.2. Predictive Testing
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Genetic Susceptibility Test
4.2.4. Predictive Diagnostics
4.2.5. Population Screening
4.3. Wellness Genomics
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Consumer Genomics
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4.3. Nutria Genetics
4.4.4. Skin & Metabolism Genetics
4.4.5. Other

Section 5. PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY APPLICATION
5.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Revenue By Application
5.2. Predictive Genetic Testing & Consumer Genomics
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.2.3. Breast & Ovarian Cancer
5.2.4. Cardiovascular screening
5.2.5. Diabetic Screening & Monitoring
5.2.6. Colon Cancer
5.2.7. Parkinsonism / Alzheimer’s Disease
5.2.8. Urologic screening/ Prostate cancer screening
5.2.9. Orthopedic & Musculoskeletal
5.2.10. Other cancer screening
5.2.11. Other

Section 6. PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY SETTING TYPE
6.1. Global Predictive Genetic Testing and Consumer Wellness Genomics Revenue By Setting Type
6.2. Professional
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. DTC
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

Section 7. NORTH AMERICA PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY COUNTRY
7.1. North America Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)

Section 8. EUROPE PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY COUNTRY
8.1. Europe Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)

Section 9. ASIA-PACIFIC PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY COUNTRY
9.1. Asia-Pacific Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)

Section 10. LATIN AMERICA PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY COUNTRY
10.1. Latin America Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)

Section 11. MIDDLE EAST PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY COUNTRY
11.1. Middle East Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)

Section 12. AFRICA PREDICTIVE GENETIC TESTING AND CONSUMER WELLNESS GENOMICS MARKET BY COUNTRY
12.1. Africa Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Predictive Genetic Testing and Consumer Wellness Genomics Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Setting Type, 2015 - 2026 ($Million)

Section 13. COMPANY PROFILE
13.1. Myriad Genetics
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Inc 23andMe, Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. F. Hoffmann-La Roche Ltd.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Thermo Fisher Scientific, Inc.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Genesis Genetics
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Abbott Laboratories
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Agilent Technologies
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. BGI
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Bio-Rad Laboratories Inc.
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Counsyl, Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Illumina, Inc.
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. ARUP Laboratories.
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies
13.13. Others
13.13.1. Company Snapshot
13.13.2. Overview
13.13.3. Financial Overview
13.13.4. Type Portfolio
13.13.5. Key Developments
13.13.6. Strategies

Section 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Request to Buy This Premium Report From Here@ https://www.visionresearchreports.com/report/cart/28946